Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Share-based Compensation: 2017-2019

Historic Share-based Compensation for Astria Therapeutics (ATXS) over the last 3 years, with Dec 2019 value amounting to $285,000.

  • Astria Therapeutics' Share-based Compensation fell 33.87% to $285,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.5 million, marking a year-over-year decrease of 14.67%. This contributed to the annual value of $13.0 million for FY2024, which is 106.56% up from last year.
  • According to the latest figures from Q4 2019, Astria Therapeutics' Share-based Compensation is $285,000, which was down 24.60% from $378,000 recorded in Q3 2019.
  • Astria Therapeutics' Share-based Compensation's 5-year high stood at $515,000 during Q3 2017, with a 5-year trough of $285,000 in Q4 2019.
  • Moreover, its 3-year median value for Share-based Compensation was $443,500 (2018), whereas its average is $440,917.
  • Data for Astria Therapeutics' Share-based Compensation shows a maximum YoY plummeted of 33.87% (in 2019) over the last 5 years.
  • Astria Therapeutics' Share-based Compensation (Quarterly) stood at $506,000 in 2017, then dropped by 14.82% to $431,000 in 2018, then crashed by 33.87% to $285,000 in 2019.
  • Its Share-based Compensation was $285,000 in Q4 2019, compared to $378,000 in Q3 2019 and $441,000 in Q2 2019.